Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a
Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului
Yüklə 4,39 Mb.
|
- Bu səhifədəki naviqasiya:
- Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
- SUBLISTA C1 - G2 BOLNAVI CU PROTEZE VALVULARE ŞI VASCULARE. Protocol: BB01I ______________________________________________________________________________ | 388
- SUBLISTA C1 - G3 BOLNAVI CU PROCEDURI INTERVENŢIONALE PERCUTANE, NUMAI DUPĂ IMPLANTAREA UNEI PROTEZE ENDOVASCULARE (STENT).
- SUBLISTA C1 - G4 HEPATITELE CRONICE DE ETIOLOGIE VIRALĂ B, C ŞI D. Protocol: LB01B; LB02E M4
Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului. ________________________________________________________________________________ DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ C03CA01 FUROSEMIDUM SOL. INJ. 10 mg/ml FUROSEMID 20 mg/2 ml 10 mg/ml ZENTIVA SA
FUROSEMID ARENA 40 mg 40 mg ARENA GROUP SA FUROSEMID EEL 40 mg BIO EEL SRL FUROSEMID LPH 40 mg 40 mg LABORMED PHARMA SA FUROSEMID MCC 40 mg 40 mg MAGISTRA C & C SRL FUROSEMID SLAVIA 40 mg SLAVIA PHARM SRL FUROSEMID ZENTIVA 40 mg ZENTIVA SA ________________________________________________________________________________ ______________________________________________________________________________ | 377 |C03DA01| SPIRONOLACTONUM | | |_______|_______|____________________________________________|_________________|
Femeile la vârsta fertilă la care s-a iniţiat tratament cu spironolactonă trebuie să ia măsuri adecvate de contracepţie. Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului. ________________________________________________________________________________ DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ C03DA01 SPIRONOLACTONUM CAPS. 100 mg VEROSPIRON 100 mg GEDEON RICHTER LTD.
SPIRONOLACTONA 25 mg 25 mg BIO EEL SRL C03DA01 SPIRONOLACTONUM COMPR. FILM. 25 mg ALSPIRON 25 mg 25 mg AC HELCOR PHARMA SRL SPIRONOLACTONA 25 mg 25 mg TERAPIA SA
VEROSPIRON 50 mg GEDEON RICHTER LTD. C03DA01 SPIRONOLACTONUM COMPR. FILM. 50 mg ALSPIRON 50 mg 50 mg AC HELCOR PHARMA SRL ________________________________________________________________________________
| 378 |C07AB02| METOPROLOLUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ C07AB02 METOPROLOLUM COMPR. 100 mg BETAPROL 100 mg 100 mg AC HELCOR PHARMA SRL BLOXAN 100 mg KRKA D.D. NOVO MESTO EGILOK 100 mg 100 mg EGIS PHARMACEUTICALS P.L.C.
METOPRO TAD 100 100 mg TAD PHARMA GMBH METOPROLOL 100 mg 100 mg OZONE LABORATORIES LTD. METOPROLOL AL 100 100 mg ALIUD(R) PHARMA GMBH & CO.KG
METOPROLOL LPH 100 mg 100 mg LABORMED PHARMA SA METOPROLOL MEDICO UNO 100 mg 100 mg MEDICO UNO PHARMACEUTICAL S.R.L. METOPROLOL TERAPIA 100 mg 100 mg TERAPIA SA VASOCARDIN(R) 100 100 mg SLOVAKOFARMA C07AB02 METOPROLOLUM COMPR. ELIB. PREL. 100 mg METOPROLOL RETARD 100 mg 100 mg TERAPIA S.A. C07AB02 METOPROLOLUM COMPR. FILM. ELIB. 100 mg PREL.
BETALOC(R) ZOC 100 mg 100 mg ASTRAZENECA AB C07AB02 METOPROLOLUM COMPR. FILM. ELIB. 190 mg MOD.
METOSUCCINAT SANDOZ 190 mg 190 mg HEXAL AG C07AB02 METOPROLOLUM SOL. INJ. 1 mg/ml BETALOC 1 mg/ml ASTRAZENECA AB C07AB02 METOPROLOLUM COMPR. ELIB. PREL. 200 mg VASOCARDIN(R) SR 200 200 mg ZENTIVA AS C07AB02 METOPROLOLUM COMPR. 25 mg EGILOK 25 mg 25 mg EGIS PHARMACEUTICALS P.L.C. METOPROLOL 25 mg 25 mg ARENA GROUP S.A. METOPROLOL LPH 25 mg 25 mg LABORMED PHARMA SA METOPROLOL MEDICO UNO 25 mg 25 mg MEDICO UNO PHARMACEUTICAL S.R.L.
MOD.
METOSUCCINAT SANDOZ 47,5 mg 47.5 mg HEXAL AG C07AB02 METOPROLOLUM COMPR. 50 mg BETAPROL 50 mg 50 mg AC HELCOR PHARMA SRL EGILOK 50 mg 50 mg EGIS PHARMACEUTICALS P.L.C. METOPRO TAD 50 50 mg TAD PHARMA GMBH METOPROLOL 50 mg 50 mg OZONE LABORATORIES LTD. METOPROLOL AL 50 50 mg ALIUD PHARMA GMBH & CO.KG METOPROLOL LPH 50 mg 50 mg LABORMED PHARMA SA METOPROLOL MEDICO UNO 50 mg 50 mg MEDICO UNO PHARMACEUTICAL S.R.L. METOPROLOL TERAPIA 50 mg 50 mg TERAPIA SA C07AB02 METOPROLOLUM COMPR. FILM. ELIB. 50 mg PREL.
BETALOC(R) ZOC 50 mg 50 mg ASTRAZENECA AB C07AB02 METOPROLOLUM COMPR. FILM. ELIB. MOD. 95 mg METOSUCCINAT SANDOZ 95 mg 95 mg HEXAL AG ________________________________________________________________________________
| 379 |C07AB07| BISOPROLOLUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ C07AB07 BISOPROLOLUM COMPR. FILM. 2.5 mg CONCOR COR 2,5 mg 2.5 mg MERCK KGAA ________________________________________________________________________________ ______________________________________________________________________________ | 380 |C07AB12| NEBIVOLOLUM** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ C07AB12 NEBIVOLOLUM COMPR. 5 mg NEBILET(R) 5 mg BERLIN CHEMIE AG MENARINI GROUP
________________________________________________________________________________ ______________________________________________________________________________ | 381 |C07AG02| CARVEDILOLUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ C07AG02 CARVEDILOLUM COMPR. 12,5 mg CARVEDILOL SANDOZ 12,5 mg HEXAL AG
ATRAM 12,5 12.5 mg ZENTIVA AS CARVEDILOL 12,5 mg 12.5 mg VIM SPECTRUM SRL CARVEDILOL HELCOR 12,5 mg 12.5 mg AC HELCOR PHARMA SRL CARVEDILOL LPH 12,5 mg 12.5 mg LABORMED PHARMA SA CARVEDILOL TEVA 12,5 mg 12.5 mg TEVA PHARMACEUTICAL S.R.L. CORYOL(R) 12.5 mg KRKA D.D. DILATREND(R) 12,5 mg 12.5 mg ROCHE ROMANIA S.R.L. TALLITON(R) 12,5 mg 12.5 mg EGIS PHARMACEUTICALS LTD.
CARVEDIGAMMA 12,5 mg 12.5 mg WORWAG PHARMA GMBH & CO.KG C07AG02 CARVEDILOLUM COMPR. 25 mg ATRAM 25 25 mg ZENTIVA AS CARVEDILOL HELCOR 25 mg 25 mg AC HELCOR PHARMA SRL CARVEDILOL LPH 25 mg 25 mg LABORMED PHARMA SA CARVEDILOL SANDOZ 25 mg HEXAL AG CARVEDILOL TEVA 25 mg 25 mg TEVA PHARMACEUTICAL S.R.L. CORYOL(R) 25 mg KRKA D.D. DILATREND(R) 25 mg 25 mg ROCHE ROMANIA S.R.L. TALLITON(R) 25 mg 25 mg EGIS PHARMACEUTICALS LTD.
CARVEDIGAMMA 25 mg 25 mg WORWAG PHARMA GMBH & CO.KG C07AG02 CARVEDILOLUM COMPR. 3.125 mg CORYOL(R) 3,125 mg 3.125 mg KRKA D.D. C07AG02 CARVEDILOLUM COMPR. 6.25 mg ATRAM 6,25 6.25 mg ZENTIVA AS CARVEDILOL 6,25 mg 6.25 mg VIM SPECTRUM SRL CARVEDILOL LPH 6,25 mg 6.25 mg LABORMED PHARMA SA CARVEDILOL SANDOZ 6.25 mg HEXAL AG CARVEDILOL TEVA 6,25 mg 6.25 mg TEVA PHARMACEUTICAL S.R.L. CORYOL(R) 6.25 mg KRKA D.D. DILATREND(R) 6,25 mg 6.25 mg ROCHE ROMANIA S.R.L. TALLITON 6,25 mg 6.25 mg EGIS PHARMACEUTICALS LTD.
CARVEDIGAMMA 6,25 mg 6.25 mg WORWAG PHARMA GMBH & CO.KG ________________________________________________________________________________
| 382 |C09AA01| CAPTOPRILUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ C09AA01 CAPTOPRILUM COMPR. 12,5 mg CAPTOPRIL MCC 12,5 mg 12,5 mg MAGISTRA C & C
CAPTOPRIL 12,5 mg 12.5 mg EGIS PHARMACEUTICALS LTD. C09AA01 CAPTOPRILUM COMPR. 25 mg CAPTOPRIL - AC 25 mg 25 mg AC HELCOR PHARMA SRL CAPTOPRIL SINTOFARM 25 mg 25 mg SINTOFARM SA CAPTOPRIL 25 EEL 25 mg BIO EEL SRL CAPTOPRIL 25 mg 25 mg EGIS PHARMACEUTICALS LTD. CAPTOPRIL LPH 25 mg 25 mg LABORMED PHARMA SA CAPTOPRIL MCC 25 mg 25 mg MAGISTRA C & C
CAPTOPRIL 50 mg 50 mg ARENA GROUP SA C09AA01 CAPTOPRILUM COMPR. 50 mg CAPTOPRIL - AC 50 mg 50 mg AC HELCOR PHARMA SRL CAPTOPRIL 50 EEL 50 mg BIO EEL SRL CAPTOPRIL 50 mg 50 mg EGIS PHARMACEUTICALS LTD. CAPTOPRIL LPH 50 mg 50 mg LABORMED PHARMA SA CAPTOPRIL MCC 50 mg 50 mg MAGISTRA C & C ________________________________________________________________________________
| 383 |C09AA02| ENALAPRILUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ C09AA02 ENALAPRILUM SOL. INJ. 1.25 mg/ml ENAP(R) 1.25 mg/ml KRKA D.D.
EDNYT(R) 10 mg 10 mg GEDEON RICHTER LTD. ENAHEXAL(R) 10 mg 10 mg HEXAL AG ENALA TAD 10 10 mg TAD PHARMA GMBH ENALAP 10 mg E.I.P.I.CO. MED S.R.L. ENALAPRIL 10 mg 10 mg MAGISTRA C & C ENALAPRIL AL 10 10 mg ALIUD(R) PHARMA GMBH & CO.KG
ENALAPRIL FABIOL 10 mg 10 mg FABIOL SA ENALAPRIL LPH 10 mg 10 mg LABORMED PHARMA SA ENALAPRIL SANDOZ 10 mg 10 mg SANDOZ SRL ENALAPRIL TERAPIA 10 mg 10 mg TERAPIA SA ENAM 10 mg 10 mg REPREZENTANTA DR. REDDY'S LABORATORIES LTD. ENAP 10 mg 10 mg KRKA D.D. NOVO MESTO RENITEC 10 mg 10 mg MERCK SHARP & DOHME ROMANIA S.R.L.
EDNYT(R) 2,5 mg 2.5 mg GEDEON RICHTER LTD. C09AA02 ENALAPRILUM COMPR. 20 mg EDNYT(R) 20 mg 20 mg GEDEON RICHTER LTD. ENAHEXAL(R) 20 mg 20 mg HEXAL AG ENALA TAD 20 20 mg TAD PHARMA GMBH ENALAPRIL 20 mg OZONE LABORATORIES LTD. ENALAPRIL 20 mg 20 mg MAGISTRA C & C ENALAPRIL AL 20 20 mg ALIUD(R) PHARMA GMBH & CO.KG
ENALAPRIL FABIOL 20 mg 20 mg FABIOL SA ENALAPRIL LPH 20 mg 20 mg LABORMED PHARMA SA ENALAPRIL SANDOZ 20 mg 20 mg SANDOZ SRL ENALAPRIL TERAPIA 20 mg 20 mg TERAPIA SA ENAP 20 mg 20 mg KRKA D.D. NOVO MESTO RENITEC 20 mg 20 mg MERCK SHARP & DOHME ROMANIA S.R.L.
EDNYT(R) 5 mg 5 mg GEDEON RICHTER LTD. ENAHEXAL(R) 5 mg 5 mg HEXAL AG ENALA TAD 5 5 mg TAD PHARMA GMBH ENALAPRIL 5 mg 5 mg OZONE LABORATORIES LTD. ENALAPRIL AL 5 5 mg ALIUD(R) PHARMA GMBH & CO.KG ENALAPRIL LPH(R) 5 mg 5 mg LABORMED PHARMA SA ENALAPRIL SANDOZ 5 mg 5 mg SANDOZ SRL ENAP 5 mg 5 mg KRKA D.D. NOVO MESTO RENITEC 5 mg 5 mg MERCK SHARP & DOHME ROMANIA S.R.L. ________________________________________________________________________________
| 384 |C09AA03| LISINOPRILUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ C09AA03 LISINOPRILUM COMPR. 10 mg LISIGAMMA 10 mg 10 mg WORWAG PHARMA GMBH & CO.KG LISINOPRIL 10 MEDO 10 mg MEDOCHEMIE ROMANIA SRL LISINOPRIL ANTIBIOTICE 10 mg 10 mg ANTIBIOTICE SA LISINOPRIL SANDOZ 10 mg 10 mg HEXAL AG LISIREN 10 mg 10 mg AC HELCOR SRL MEDAPRIL 10 10 mg MEDOCHEMIE LTD. RANOLIP 10 mg RANBAXY U.K. LIMITED SINOPRYL(R) 10 10 mg ECZACIBASI PHARMACEUTICALS S.R.L. TONOLYSIN 10 mg 10 mg GEDEON RICHTER LTD. C09AA03 LISINOPRILUM COMPR. 2.5 mg TONOLYSIN 2,5 mg 2.5 mg GEDEON RICHTER LTD. C09AA03 LISINOPRILUM COMPR. 20 mg LISIGAMMA 20 mg 20 mg WORWAG PHARMA GMBH & CO.KG LISINOPRIL 20 MEDO 20 mg MEDOCHEMIE ROMANIA SRL LISINOPRIL ANTIBIOTICE 20 mg 20 mg ANTIBIOTICE SA LISINOPRIL SANDOZ 20 mg 20 mg HEXAL AG LISIREN 20 mg 20 mg AC HELCOR SRL MEDAPRIL 20 20 mg MEDOCHEMIE LTD. RANOLIP 20 mg RANBAXY U.K. LIMITED TONOLYSIN 20 mg 20 mg GEDEON RICHTER LTD.
LISINOPRIL ANTIBIOTICE 40 mg 40 mg ANTIBIOTICE SA C09AA03 LISINOPRILUM COMPR. 5 mg LISIGAMMA 5 mg 5 mg WORWAG PHARMA GMBH & CO.KG LISINOPRIL 5 MEDO 5 mg MEDOCHEMIE ROMANIA SRL LISINOPRIL SANDOZ 5 mg 5 mg HEXAL AG MEDAPRIL 5 5 mg MEDOCHEMIE LTD. RANOLIP 5 mg RANBAXY U.K. LIMITED TONOLYSIN 5 mg 5 mg GEDEON RICHTER LTD. ________________________________________________________________________________ ______________________________________________________________________________ | 385 |C09AA05| RAMIPRILUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ C09AA05 RAMIPRILUM COMPR. FILM. 1.25 mg RAMIRAN 1,25 mg 1.25 mg RANBAXY U.K. LIMITED
EMREN 10 mg 10 mg GEDEON RICHTER ROMANIA S.A. VIVACE 10 mg 10 mg ACTAVIS GROUP HF C09AA05 RAMIPRILUM COMPR. 10 mg AMPRIL 10 mg 10 mg KRKA D.D. NOVO MESTO PIRAMIL 10 mg 10 mg SANDOZ SRL RAMIGAMMA 10 mg 10 mg WORWAG PHARMA GMBH & CO.KG RAMIPRIL-AC 10 mg 10 mg AC HELCOR PHARMA SRL TRITACE 10 10 mg SANOFI-AVENTIS DEUTSCHLAND GMBH ZENRA 10 10 mg ZENTIVA S.A. C09AA05 RAMIPRILUM COMPR. FILM. 10 mg RAMIRAN 10 mg 10 mg RANBAXY U.K. LIMITED C09AA05 RAMIPRILUM COMPR. 2,5 mg EMREN 2,5 mg 2,5 mg GEDEON RICHTER ROMANIA SA VIVACE 2,5 mg 2,5 mg ACTAVIS GROUP HF
AMPRIL 2,5 mg 2.5 mg KRKA D.D. NOVO MESTO PIRAMIL 2,5 mg 2.5 mg SANDOZ SRL RAMIPRIL-AC 2,5 mg 2.5 mg AC HELCOR PHARMA SRL TRITACE(R) 2,5 2.5 mg AVENTIS PHARMA DEUTSCHLAND GMBH
ZENRA 2,5 2.5 mg ZENTIVA S.A. C09AA05 RAMIPRILUM COMPR. FILM. 2.5 mg RAMIRAN 2,5 mg 2.5 mg RANBAXY U.K. LIMITED C09AA05 RAMIPRILUM COMPR. 5 mg EMREN 5 mg 5 mg GEDEON RICHTER ROMANIA S.A. VIVACE 5 mg 5 mg ACTAVIS GROUP HF C09AA05 RAMIPRILUM COMPR. 5 mg AMPRIL 5 mg 5 mg KRKA D.D. NOVO MESTO PIRAMIL 5 mg 5 mg SANDOZ SRL RAMIGAMMA 5 mg 5 mg WORWAG PHARMA GMBH & CO.KG RAMIPRIL-AC 5 mg 5 mg AC HELCOR PHARMA SRL TRITACE(R) 5 5 mg AVENTIS PHARMA DEUTSCHLAND GMBH ZENRA 5 5 mg ZENTIVA S.A. C09AA05 RAMIPRILUM COMPR. FILM. 5 mg RAMIRAN 5 mg 5 mg RANBAXY U.K. LIMITED ________________________________________________________________________________
| 386 |C09CA03| VALSARTANUM** | Protocol: C005I | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ C09CA03 VALSARTANUM COMPR. FILM. 160 mg DIOVAN 160 mg 160 mg NOVARTIS PHARMA GMBH
DIOVAN 80 mg 80 mg NOVARTIS PHARMA GMBH ________________________________________________________________________________
| 387 |C09CA06| CANDESARTANUM CILEXETIL** | Protocol: C005I | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ C09CA06 CANDESARTANUM COMPR. 16 mg CILEXETIL ATACAND 16 mg ASTRAZENECA AB C09CA06 CANDESARTANUM COMPR. 8 mg CILEXETIL ATACAND 8 mg ASTRAZENECA AB ________________________________________________________________________________ SUBLISTA C1 - G2 BOLNAVI CU PROTEZE VALVULARE ŞI VASCULARE. Protocol: BB01I ______________________________________________________________________________ | 388 |B01AA07| ACENOCUMAROLUM* | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ B01AA07 ACENOCUMAROLUM COMPR. 2 mg TROMBOSTOP 2 mg 2 mg TERAPIA SA
SINTROM(R) 4 mg NOVARTIS PHARMA GMBH ________________________________________________________________________________
| 389 |B01AC04| CLOPIDOGRELUM*** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ B01AC04 CLOPIDOGRELUM COMPR. FILM. 75 mg PLAVIX 75 mg 75 mg SANOFI PHARMA - BRISTOL MYERS SQUIBB ________________________________________________________________________________
______________________________________________________________________________ | 392 |J05AB04| RIBAVIRINUM**** | Protocol: J002N | |_______|_______|____________________________________________|_________________| ________________________________________________________________________________ DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J05AB04 RIBAVIRINUM CAPS. 200 mg REBETOL 200 mg 200 mg SP EUROPE
COPEGUS(R) 200 mg ROCHE ROMANIA SRL ________________________________________________________________________________
| 393 |J05AF05| LAMIVUDINUM**** | Protocol: J005N | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J05AF05 LAMIVUDINUM COMPR. FILM. 100 mg ZEFFIX 100 mg 100 mg GLAXO GROUP LTD.
EPIVIR 10 mg/ml 10 mg/ml GLAXO GROUP LTD. J05AF05 LAMIVUDINUM COMPR. FILM. 150 mg EPIVIR 150 mg 150 mg GLAXO GROUP LTD. J05AF05 LAMIVUDINUM SOL. ORALĂ 5 mg/ml ZEFFIX 5 mg/ml 5 mg/ml GLAXO GROUP LTD. ________________________________________________________________________________
| 395 |J05AF10| ENTECAVIRUM**** | Protocol: J008N | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J05AF10 ENTECAVIRUM COMPR. FILM. 0,5 mg BARACLUDE 0,5 mg 0,5 mg BRISTOL-MYERS SQUIBB PHARMA EEIG J05AF10 ENTECAVIRUM COMPR. FILM. 1 mg BARACLUDE 1 mg 1 mg BRISTOL-MYERS SQUIBB PHARMA EEIG ________________________________________________________________________________ ______________________________________________________________________________ | 396 |L03AA02| FILGRASTIMUM (G-CSF)** | Protocol: B013K | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L03AA02 FILGRASTIMUM (G-CSF) SOL. INJ. 30 MU/0.5 ml NEUPOGEN(R) 30 MU/0.5 ml AMGEN EUROPE B.V.
NEUPOGEN(R) 48 MU/0.5 ml AMGEN EUROPE B.V. ________________________________________________________________________________
| 397 |L03AB04| INTERFERONUM ALFA 2a**** | Protocol: J007N | |_______|_______|____________________________________________|_________________|
Yüklə 4,39 Mb. Dostları ilə paylaş:
|